CTX112
CRSP-AID-500
Phase 1 mab active
Quick answer
CTX112 for SLE (Systemic Lupus) is a Phase 1 program (mab) at CRISPR Therapeutics AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CRISPR Therapeutics AG
- Indication
- SLE (Systemic Lupus)
- Phase
- Phase 1
- Modality
- mab
- Status
- active